W Danielczyk

2.5k total citations
77 papers, 1.8k citations indexed

About

W Danielczyk is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, W Danielczyk has authored 77 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Neurology, 16 papers in Psychiatry and Mental health and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in W Danielczyk's work include Parkinson's Disease Mechanisms and Treatments (23 papers), Neurological disorders and treatments (16 papers) and Alzheimer's disease research and treatments (14 papers). W Danielczyk is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (23 papers), Neurological disorders and treatments (16 papers) and Alzheimer's disease research and treatments (14 papers). W Danielczyk collaborates with scholars based in Austria, Germany and Switzerland. W Danielczyk's co-authors include Peter Fischer, K. A. Jellinger, Peter Riederer, M Simányi, Gerald Gatterer, W Birkmayer, Peter Riederer, Johannes Kornhuber, W. Gsell and E Neumayer and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Biological Psychiatry.

In The Last Decade

W Danielczyk

73 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W Danielczyk Austria 24 645 539 509 488 382 77 1.8k
J Constantinidis Switzerland 24 544 0.8× 711 1.3× 667 1.3× 438 0.9× 419 1.1× 88 2.0k
Robert Perry United Kingdom 14 355 0.6× 434 0.8× 388 0.8× 436 0.9× 396 1.0× 19 1.9k
Urpo K. Rinne Finland 24 1.5k 2.3× 743 1.4× 394 0.8× 356 0.7× 256 0.7× 44 2.3k
E.G. Spokes United Kingdom 17 896 1.4× 1.1k 2.0× 233 0.5× 363 0.7× 554 1.5× 23 1.9k
D.M.A. Mann United Kingdom 19 346 0.5× 495 0.9× 1.4k 2.8× 498 1.0× 807 2.1× 36 2.2k
R. F. Dannals United States 16 551 0.9× 778 1.4× 199 0.4× 289 0.6× 441 1.2× 33 1.9k
Daniele Bravi Italy 22 649 1.0× 485 0.9× 220 0.4× 387 0.8× 312 0.8× 38 1.5k
G. S. Sarna United Kingdom 24 317 0.5× 962 1.8× 264 0.5× 180 0.4× 648 1.7× 38 1.9k
Scott A. Reines United States 23 211 0.3× 565 1.0× 814 1.6× 664 1.4× 590 1.5× 37 2.8k
Gay Rudow United States 20 767 1.2× 653 1.2× 1.1k 2.2× 527 1.1× 575 1.5× 25 2.2k

Countries citing papers authored by W Danielczyk

Since Specialization
Citations

This map shows the geographic impact of W Danielczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Danielczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Danielczyk more than expected).

Fields of papers citing papers by W Danielczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Danielczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Danielczyk. The network helps show where W Danielczyk may publish in the future.

Co-authorship network of co-authors of W Danielczyk

This figure shows the co-authorship network connecting the top 25 collaborators of W Danielczyk. A scholar is included among the top collaborators of W Danielczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Danielczyk. W Danielczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scholz, Claus Jürgen, Heike Weber, Susanne Jungwirth, et al.. (2017). Explorative results from multistep screening for potential genetic risk loci of Alzheimer’s disease in the longitudinal VITA study cohort. Journal of Neural Transmission. 125(1). 77–87. 8 indexed citations
2.
Bartl, Jasmin, Claus Jürgen Scholz, Susanne Jungwirth, et al.. (2011). Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzymegene. BMC Medical Genetics. 12(1). 151–151. 8 indexed citations
3.
Grünblatt, Edna, Andreas Reif, Susanne Jungwirth, et al.. (2011). Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer’s disease: The VITA and Milano studies. Journal of Psychiatric Research. 45(9). 1250–1256. 14 indexed citations
4.
Danielczyk, W, et al.. (2009). Ideomotor apraxia in Alzheimer's disease. Acta Neurologica Scandinavica. 88(1). 1–4. 7 indexed citations
5.
Grünblatt, Edna, Sonja Zehetmayer, Jasmin Bartl, et al.. (2008). Genetic risk factors and markers for Alzheimer’s disease and/or depression in the VITA study. Journal of Psychiatric Research. 43(3). 298–308. 44 indexed citations
6.
Brenner, Markus, Núria Durany, Gerhard Ransmayr, et al.. (2003). Up-regulation of striatal adenosine A2A receptors in schizophrenia. Neuroreport. 14(3). 313–316. 46 indexed citations
7.
Durany, Núria, Robert Zöchling, Werner Paulus, et al.. (2000). Human post-mortem striatal α4β2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome. Neuroscience Letters. 287(2). 109–112. 89 indexed citations
8.
Götz, Mario E., Peter Fischer, W. Gsell, et al.. (1998). Platelet Monoamine Oxidase B Activity in Dementia. Dementia and Geriatric Cognitive Disorders. 9(2). 74–77. 23 indexed citations
9.
Kornhuber, Johannes, G. Quack, Wojciech Danysz, et al.. (1995). Therapeutic brain concentration of the NMDA receptor antagonist amantadine. Neuropharmacology. 34(7). 713–721. 99 indexed citations
10.
Przuntek, H., D. Welzel, W Danielczyk, et al.. (1992). Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued. European Journal of Clinical Pharmacology. 43(4). 357–363. 49 indexed citations
11.
Fischer, Peter, W Danielczyk, K. A. Jellinger, et al.. (1991). Clinico pathological classification of dementia. Der Nervenarzt. 62(7). 408–414. 1 indexed citations
12.
Jellinger, K. A., et al.. (1990). Clinicopathological analysis of dementia disorders in the elderly. Journal of the Neurological Sciences. 95(3). 239–258. 182 indexed citations
13.
Gatterer, Gerald, Peter Fischer, & W Danielczyk. (1989). Variation of cognitive parameters in the progress of dementia. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 1(1-2). 69–69. 1 indexed citations
14.
Gatterer, Gerald, Peter Fischer, M Simányi, & W Danielczyk. (1989). The A-K-T ("Alters-Konzentrations-Test") a new psychometric test for geriatric patients.. PubMed. 4(3). 273–6. 14 indexed citations
15.
Danielczyk, W, F. Forette, Jean‐Marc Orgogozo, et al.. (1988). CBM 36‐733 (2‐Methyl‐alpha‐ergokryptine) In primary degenerative dementia: Results of a european multicentre trial. International Journal of Geriatric Psychiatry. 3(2). 107–114. 1 indexed citations
16.
Fischer, Peter, et al.. (1988). Nonspecificity of Semantic Impairment in Dementia of Alzheimer's Type. Archives of Neurology. 45(12). 1341–1343. 38 indexed citations
17.
Danielczyk, W, M. Streifler, Christine Konradi, Peter Riederer, & G. Moll. (1988). Platelet MAO‐B activity and the psychopathology of Parkinson's disease, senile dementia and multi‐infarct dementia. Acta Psychiatrica Scandinavica. 78(6). 730–736. 55 indexed citations
18.
Ambrozi, L & W Danielczyk. (1988). Treatment of Impaired Cerebral Function in Psychogeriatric Patients with Memantine - Results of a Phase II Double-Blind Study. Pharmacopsychiatry. 21(3). 144–146. 39 indexed citations
19.
Danielczyk, W. (1979). [Acute pharmacotoxic psychoses in patients with chronic cerebral disorders].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 55. 1–15. 2 indexed citations
20.
Birkmayer, W, et al.. (1976). Biogene Transmitter und Akupunktur. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Constantinidis Breakdown of academic impact, for papers by Robert Perry Breakdown of academic impact, for papers by Urpo K. Rinne Breakdown of academic impact, for papers by E.G. Spokes Breakdown of academic impact, for papers by D.M.A. Mann Breakdown of academic impact, for papers by R. F. Dannals Breakdown of academic impact, for papers by Daniele Bravi Breakdown of academic impact, for papers by G. S. Sarna Breakdown of academic impact, for papers by Scott A. Reines Breakdown of academic impact, for papers by Gay Rudow
Rankless by CCL
2026